Medical Therapy for Ulcerative Colitis.
From: Section of Gastroenterology and Hepatology, University of Chicago, Pritzker School of Medicine, Chicago, Illinois 60637, USA. shanauer@medicine.bsd.uchicago.edu
Current opinion in gastroenterology
- Publish Date: Jul 2000
- ISSN: 0267-1379
- Volume: 16
- Issue: 4
- Pages: 324-8
- Medium: Print
- Language: English
- Citation (JAMA): Hanauer S B, et al. Medical Therapy for Ulcerative Colitis.. Curr. Opin. Gastroenterol. Jul 2000;16:324-8
Abstract
Last year was not a banner year for developments in medical therapy for ulcerative colitis. In contrast to the expansion of therapies for Crohn disease, treatment for ulcerative colitis was evolutionary, at best, leading many patients to seek alternative medical approaches. Nevertheless, there have been advances in the application of aminosalicylates and immune modifiers for ulcerative colitis. Additional, nonconventional approaches include nicotine, probiotics, dietary therapies, and heparins. Several novel approaches have arisen from animal models, including additional means of inhibiting nuclear factor-kappaB and targeting of tumor necrosis factor-alpha.
Mesh Headings (Keywords):
Check for Full Text / PubMed Unique Identifier (PMID): 17031096
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.